Anpario Plc (ANP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anpario Plc (ANP) has a cash flow conversion efficiency ratio of 0.037x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX1.44 Million ≈ $175.69 USD) by net assets (GBX39.05 Million ≈ $4.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anpario Plc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Anpario Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Anpario Plc total liabilities for a breakdown of total debt and financial obligations.
Anpario Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anpario Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lithium One Metals Inc
V:LONE
|
-0.004x |
|
SIG plc
LSE:SHI
|
0.208x |
|
MTI Investment SE
ST:MTI
|
-0.062x |
|
Condmag Brasov
RO:COMI
|
0.042x |
|
Bioventix
LSE:BVXP
|
0.319x |
|
Lifeist Wellness Inc
V:LFST
|
-0.325x |
|
Metavisio (Thomson Computing)
PA:ALTHO
|
0.002x |
|
Tres Or Resources Ltd
V:TRS
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Anpario Plc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Anpario Plc from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see ANP stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX36.29 Million ≈ $4.42K |
GBX5.84 Million ≈ $710.92 |
0.161x | -37.70% |
| 2023-12-31 | GBX33.65 Million ≈ $4.09K |
GBX8.70 Million ≈ $1.06K |
0.258x | +882.05% |
| 2022-12-31 | GBX41.31 Million ≈ $5.03K |
GBX1.09 Million ≈ $132.26 |
0.026x | -66.28% |
| 2021-12-31 | GBX40.30 Million ≈ $4.90K |
GBX3.15 Million ≈ $382.66 |
0.078x | -49.80% |
| 2020-12-31 | GBX37.51 Million ≈ $4.56K |
GBX5.83 Million ≈ $709.34 |
0.155x | +39.21% |
| 2019-12-31 | GBX35.55 Million ≈ $4.33K |
GBX3.97 Million ≈ $483.03 |
0.112x | +37.65% |
| 2018-12-31 | GBX33.15 Million ≈ $4.03K |
GBX2.69 Million ≈ $327.17 |
0.081x | -52.69% |
| 2017-12-31 | GBX30.52 Million ≈ $3.71K |
GBX5.23 Million ≈ $636.83 |
0.171x | +28.85% |
| 2016-12-31 | GBX28.54 Million ≈ $3.47K |
GBX3.80 Million ≈ $462.11 |
0.133x | +4.24% |
| 2015-12-31 | GBX26.58 Million ≈ $3.23K |
GBX3.39 Million ≈ $412.95 |
0.128x | -10.56% |
| 2014-12-31 | GBX22.75 Million ≈ $2.77K |
GBX3.25 Million ≈ $395.07 |
0.143x | -1.70% |
| 2013-12-31 | GBX20.13 Million ≈ $2.45K |
GBX2.92 Million ≈ $355.64 |
0.145x | +19.68% |
| 2012-12-31 | GBX17.89 Million ≈ $2.18K |
GBX2.17 Million ≈ $264.03 |
0.121x | -3.65% |
| 2011-12-31 | GBX16.00 Million ≈ $1.95K |
GBX2.02 Million ≈ $245.17 |
0.126x | +83.64% |
| 2010-12-31 | GBX14.79 Million ≈ $1.80K |
GBX1.01 Million ≈ $123.37 |
0.069x | -55.15% |
| 2009-12-31 | GBX13.61 Million ≈ $1.66K |
GBX2.08 Million ≈ $253.08 |
0.153x | +166.70% |
| 2008-12-31 | GBX7.54 Million ≈ $916.91 |
GBX432.00K ≈ $52.56 |
0.057x | -37.23% |
| 2007-12-31 | GBX7.13 Million ≈ $867.27 |
GBX651.00K ≈ $79.21 |
0.091x | +137.05% |
| 2006-12-31 | GBX6.76 Million ≈ $822.74 |
GBX-1.67 Million ≈ $-202.83 |
-0.247x | +15.15% |
| 2005-12-31 | GBX1.86 Million ≈ $226.55 |
GBX-541.00K ≈ $-65.82 |
-0.291x | +62.61% |
| 2004-12-31 | GBX619.00K ≈ $75.31 |
GBX-481.00K ≈ $-58.52 |
-0.777x | -109.73% |
| 2003-12-31 | GBX-61.00K ≈ $-7.42 |
GBX-487.00K ≈ $-59.25 |
7.984x | -89.29% |
| 2002-12-31 | GBX-15.00K ≈ $-1.83 |
GBX-1.12 Million ≈ $-136.03 |
74.533x | -- |
About Anpario Plc
Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed… Read more